Article thumbnail

Screening for Cytomegalovirus during Pregnancy

By Stuart P. Adler

Abstract

The epidemiology and pathogenesis of CMV infections among pregnant women have been intensely studied over the last three decades. This paper highlights recent developments that make either universal or limited serologic screening for CMV during pregnancy potentially attractive. The developments include an understanding of the pathogenesis of CMV infections, a knowledge of high-risk women, the availability of accurate methods for the serologic diagnosis of a primary CMV infection using either single or serial blood samples, accurate methods for the diagnosis of fetal infection via amniotic fluid, sensitive fetal and placental indicators for neonatal outcomes, and the availability of potentially effective interventions

Topics: Review Article
Publisher: Hindawi Publishing Corporation
OAI identifier: oai:pubmedcentral.nih.gov:3152970
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2007). A thoughtful algorithm for the accurate diagnosis of primary CMV infection in pregnancy,”
  2. American College of Obstetricians and Gynecologists, Perinatal Viral and Parasitic Infections,
  3. (2010). Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection,”
  4. (1999). Anticytomegalovirus (Anti-CMV) immunoglobulin G avidity in identification of pregnant women at risk of transmitting congenital
  5. (2009). Clinical predictive value of real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples,”
  6. (1997). Clinical uses of intravenous immunoglobulininpregnancy,”AmericanJournalofObstetrics and Gynecology,
  7. (2007). Congenital cytomegalovirus infection—a question of screening,”
  8. (2007). Cost-effectiveness of antenatal maternal CMV serologic screening for reduction ofcongenitalCMVsequelae,”inProceedingsofthe34thAnnual Meeting of the Infectious Disease Society for Obstetrics and Gynecology,
  9. (1967). Cytomegalic inclusion disease. The fetal disorder,”
  10. (1989). Cytomegalovirus and child day care: evidence for an increased infection rate among day-care workers,”
  11. (1991). Cytomegalovirus and child day care: risk factors for maternal infection,”
  12. (2010). Cytomegalovirus infection in pregnancy,”
  13. (2004). Cytomegalovirus,” in Hospital Epidemiology and Infection Control,
  14. (2002). Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant,”
  15. (2009). Does hygiene counseling have an impact on the rate of CMV primary infection during pregnancy? Results of a 3-year prospective study in a French hospital,”
  16. (2006). e o n ,M .V i c t o r ,S .P .A d l e re ta l . ,“ K n o w l e d g ea n da w a r e n e s s of congenital cytomegalovirus among women,”
  17. (1990). Effectiveness and cost benefit of a proposed live cytomegalovirus vaccine in the prevention of congenital disease,” R e v i e w so fI n f e c t i o u sD i s e a s e s ,
  18. (1985). Epidemiology of cytomegalovirus infections in young children: day care vs. home care,” Pediatric Infectious Disease,
  19. (2009). Evaluation of the new architect cytomegalovirus immunoglobulin
  20. (1992). F o w l e r ,S .S t a g n o ,R .F .P a s s ,W .J .B r i t t ,T .J .B o l l ,a n d
  21. (2006). Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunity,”
  22. (1985). Herpesvirus infections of pregnancy. Part I: cytomegalovirus and Epstein-Barr virus infections,”
  23. (2010). Human cytomegalovirus in utero transmission: follow-up of 524 maternal seroconversions,”
  24. (1995). Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age,”
  25. (2007). Impact of diagnostic and confirmatory tests and prenatal counseling on the rate of pregnancy termination among women with positive cytomegalovirus immunoglobulin M antibody titers,”
  26. (2007). Incidence of cytomegalovirus infection among the general population and pregnant women in the United States,”
  27. (1986). Increased rate of CMV infection among parents of children attending daycare centers,” The New England
  28. (1990). Increased rate of cytomegalovirus infection among day care center workers,”
  29. Interim analysis of the cytotect(R) phase III trial in congenital cytomegalovirus (CMV) infection shows clear indication of efficacy,” http://www.tradesignalonline .com/charts/news.aspx?id=744444&filter=&catid=0.
  30. (2008). Kowledge and practices of obstetricians and gynecologists regarding cytomegalovirus infection during pregnancy,”
  31. (2010). Laboratory evaluation of the new access cytomegalovirus immunoglobulin
  32. (2003). Maternal immunity and prevention of congenital cytomegalovirus infection,”
  33. (1994). Mechanisms of action of intravenous immune serum globulin therapy,”
  34. (1991). Molecular epidemiology of cytomegalovirus: a studyoffactorsaffectingtransmissionamongchildrenatthree day-care centers,”
  35. (2006). Newborn hearing screening—a silent revolution,” The New England
  36. (2000). Passive immunity in prevention and treatment of infectious diseases,”
  37. (2005). Passive immunization during pregnancy for congenital cytomegalovirus infection,” The New England
  38. (2006). Placental enlargement in women with primary maternal cytomegalovirusinfectionisassociatedwithfetalandneonatal disease,”
  39. (2010). Positive predictive value of anti-HCMV IgM as an index of primaryinfection,”JournalofVirologicalMethods,vol.168,no. 1-2,
  40. (1993). Prenatal diagnosis of 52 pregnancies at risk for congenital cytomegalovirus infection,”
  41. (1997). Prenatal diagnosis of fetal primary cytomegalovirus infection,”Obstetrics&Gynecology,vol.89,no.5,pp.763–767,
  42. (2004). Prevention of child-to-mother transmission of cytomegalovirus among pregnant women,”
  43. (1996). Prevention of child-to-mother transmission of cytomegalovirus by changing behaviors: a randomized controlled trial,”
  44. (2009). Prevention of congenital and perinatal infections,”
  45. (2007). Primary versus nonprimary cytomegalovirus infection during pregnancy,
  46. (2006). Progress towards interrupting intrauterine transmission of cytomegalovirus?”
  47. (2009). r a n c i s s e ,P .R e v e l a r d ,V .D eM a e r t e l a e r
  48. (2002). Real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples from mothers with primary infection,”
  49. (2008). Regression of fetal cerebral abnormalities by primary cytomegalovirus infection following hyperimmunoglobulin therapy,”
  50. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection,”
  51. (2006). Risk factors for congenital cytomegalovirus infection in the offspring of young women:
  52. (2007). Routine screening for CMV in pregnancy: opening the pandora box?”
  53. (2009). Screeningandtreatingforprimarycytomegalovirusinfection in pregnancy: where do we stand? A decision-analytic and economic analysis,”
  54. The frequency of pregnancy and exposure to cytomegalovirus (CMV) infections among women with a young child in day care,”
  55. (1991). The occupational risk of cytomegalovirus infection among day-care providers,”
  56. (2008). The prognostic value of ultrasound abnormalities and biological parameters in blood of fetuses infected with cytomegalovirus,”
  57. (2008). u e r r a ,G .S i m o n a z z i ,C .P u c c e t t ie ta l . ,“ U l t r a s o u n dp r e -diction of symptomatic congenital cytomegalovirus infection,”
  58. (2009). Vaccine prevention of maternal cytomegalovirus infection,”
  59. (2001). Vaccines for the 21st Century: A Tool for Decisionmaking, National Academy Press,
  60. (2005). Washing our hands of the congenital cytomegalovirus disease epidemic,”